Tumor cells in colorectal cancer exploit an important signaling pathway that normally controls embryo development.

Inobrodib is being developed as a first-in-class oral cancer drug that the company says will be able to treat not only ...

A study has uncovered a surprising link between diet, intestinal microbes and the efficacy of cancer therapy. A Ludwig Cancer Research study has uncovered a surprising link between diet, intestinal ...

A recent report found that women account for two-thirds of all cancers diagnosed in people under 50. But it's not all bad news.

Amidst the continued struggle to treat non-small-cell lung cancer, a new study led by Stanford University scientists suggests that a patient's response to immunotherapy may hinge on how immune cells ...

From a biomarker-driven strategy to delay or avoid cystectomy, to practice-changing perioperative immunotherapy, developments ...

Scientists aiming to advance cancer diagnostics have developed a machine learning tool that is able to identify metabolism-related molecular profile differences between patients with colorectal cancer ...

Cells are the smallest units of life. But even within the same tissue or organ, they are not all identical. New variations arise continuously during cell proliferation. While genetic mutations alter ...

Other Metabolic Alterations in Cancer: Current Therapeutic Targets A number of different kinds of genetic mutations have been associated with the dysregulation of metabolic pathways in various tumor ...

Somatic hypermutation (SHM) of immunoglobulin variable (V) regions modulates antibody-antigen affinity is initiated by activation-induced cytidine deaminase (AID) on single-stranded DNA (ssDNA).

In the realm of oncology, understanding the genetic and genomic alterations that drive cancer progression is crucial.